|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 515 for Il1rl1

<< First    < Previous  |  Next >    Last >>
0.031s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
GXD Expression
GXD Expression
 
Probe: MGI:3132664
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3596123
Pattern: Spotted
Stage: TS23
Assay Id: MGI:4825576
Age: embryonic day 14.5
Image: euxassay_006538_20
Specimen Label: euxassay_006538_20
Detected: true
Specimen Num: 20
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:3132664
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3596123
Pattern: Spotted
Stage: TS23
Assay Id: MGI:4825576
Age: embryonic day 14.5
Image: euxassay_006538_21
Specimen Label: euxassay_006538_21
Detected: true
Specimen Num: 21
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:3132664
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3596123
Pattern: Spotted
Stage: TS23
Assay Id: MGI:4825576
Age: embryonic day 14.5
Image: euxassay_006538_22
Specimen Label: euxassay_006538_22
Detected: true
Specimen Num: 22
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:3132664
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3596123
Pattern: Spotted
Stage: TS23
Assay Id: MGI:4825576
Age: embryonic day 14.5
Image: euxassay_006538_23
Specimen Label: euxassay_006538_23
Detected: true
Specimen Num: 23
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5643767
Assay Type: RNA in situ
Annotation Date: 2015-07-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3276026
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:5643769
Age: embryonic day 19.0
Image: 6A, B/C
Specimen Label: 6A, B/C
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5643768
Assay Type: RNA in situ
Annotation Date: 2015-07-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3276028
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:5643770
Age: postnatal adult
Image: 6D
Specimen Label: 6D
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5643767
Assay Type: RNA in situ
Annotation Date: 2015-07-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1684624
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:5643769
Age: embryonic day 16.0
Image: 3A/B
Specimen Label: 3A/B
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5643768
Assay Type: RNA in situ
Annotation Date: 2015-07-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1684624
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:5643770
Age: embryonic day 16.0
Image: 3C/D
Specimen Label: 3C/D
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5643766
Assay Type: RNA in situ
Annotation Date: 2015-07-08
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1877126
Pattern: Regionally restricted
Stage: TS26
Assay Id: MGI:5643855
Age: embryonic day 18.0
Image: 11A
Note: Expression is in the epithelial parts.
Specimen Label: 11A
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5643766
Assay Type: RNA in situ
Annotation Date: 2015-07-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1801025
Pattern: Regionally restricted
Stage: TS25
Assay Id: MGI:5643855
Age: embryonic day 17.0
Image: 10A, B/D
Note: Expression is in osteoblasts, absent in cartilage.
Specimen Label: 10A, B/D
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5643766
Assay Type: RNA in situ
Annotation Date: 2015-07-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1752726
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:5643855
Age: embryonic day 18.0
Image: 11A
Specimen Label: 11A
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5643858
Assay Type: Immunohistochemistry
Annotation Date: 2015-07-08
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1752726
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:5643863
Age: embryonic day 18.0
Image: 11B
Specimen Label: 11B
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5643858
Assay Type: Immunohistochemistry
Annotation Date: 2015-07-08
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757525
Pattern: Not Specified
Stage: TS25
Assay Id: MGI:5643863
Age: embryonic day 17.0
Image: 9E
Specimen Label: 9E
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:5643766
Assay Type: RNA in situ
Annotation Date: 2015-07-08
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757525
Stage: TS25
Assay Id: MGI:5643855
Age: embryonic day 17.0
Image: 9A, C/D
Specimen Label: 9A, C/D
Detected: false
Specimen Num: 1
•
•
•
•
•
Publication
8131748 | J:17250
First Author: Bergers G
Year: 1994
Journal: EMBO J
Title: Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor.
Volume: 13
Issue: 5
Pages: 1176-88
•
•
•
•
•
Publication
23536294 | J:196177
First Author: Wen T
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo.
Volume: 110
Issue: 15
Pages: 6067-72
•
•
•
•
•
Publication
31057534 | J:284373
 
First Author: Ryffel B
Year: 2019
Journal: Front Immunol
Title: Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression.
Volume: 10
Pages: 702
•
•
•
•
•
Publication
30318149 | J:268638
First Author: Cohen M
Year: 2018
Journal: Cell
Title: Lung Single-Cell Signaling Interaction Map Reveals Basophil Role in Macrophage Imprinting.
Volume: 175
Issue: 4
Pages: 1031-1044.e18
•
•
•
•
•
Publication
36878383 | J:334736
     
First Author: Brandt EB
Year: 2023
Journal: J Allergy Clin Immunol
Title: Thymic stromal lymphopoietin rather than IL-33 drives food allergy after epicutaneous sensitization to food allergen.
•
•
•
•
•
Publication
37347461 | J:338082
 
First Author: Maes B
Year: 2023
Journal: J Exp Med
Title: STE20 kinase TAOK3 regulates type 2 immunity and metabolism in obesity.
Volume: 220
Issue: 9
•
•
•
•
•
Publication
7916701 | J:17554
First Author: Yanagisawa K
Year: 1993
Journal: FEBS Lett
Title: Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1.
Volume: 318
Issue: 1
Pages: 83-7
•
•
•
•
•
Publication
16286016 | J:113336
First Author: Schmitz J
Year: 2005
Journal: Immunity
Title: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Volume: 23
Issue: 5
Pages: 479-90
•
•
•
•
•
Publication
21674479 | J:176814
First Author: Hueber AJ
Year: 2011
Journal: Eur J Immunol
Title: IL-33 induces skin inflammation with mast cell and neutrophil activation.
Volume: 41
Issue: 8
Pages: 2229-37
•
•
•
•
•
Publication
20139274 | J:159640
First Author: Xu D
Year: 2010
Journal: J Immunol
Title: IL-33 exacerbates autoantibody-induced arthritis.
Volume: 184
Issue: 5
Pages: 2620-6
•
•
•
•
•
Publication
29867945 | J:311058
 
First Author: Staurengo-Ferrari L
Year: 2018
Journal: Front Immunol
Title: Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-Induced Septic Arthritis.
Volume: 9
Pages: 962
•
•
•
•
•
Publication
28784844 | J:251496
First Author: Garth JM
Year: 2017
Journal: J Immunol
Title: IL-33 Signaling Regulates Innate IL-17A and IL-22 Production via Suppression of Prostaglandin E2 during Lung Fungal Infection.
Volume: 199
Issue: 6
Pages: 2140-2148
•
•
•
•
•
Publication
29436517 | J:290686
First Author: Ferhat M
Year: 2018
Journal: J Am Soc Nephrol
Title: Endogenous IL-33 Contributes to Kidney Ischemia-Reperfusion Injury as an Alarmin.
Volume: 29
Issue: 4
Pages: 1272-1288
•
•
•
•
•
Publication
23523996 | J:201356
 
First Author: Han P
Year: 2013
Journal: Neuroscience
Title: Interleukin-33 mediates formalin-induced inflammatory pain in mice.
Volume: 241
Pages: 59-66
•
•
•
•
•
Publication
32296080 | J:289784
First Author: Pietka W
Year: 2020
Journal: Sci Rep
Title: Lack of interleukin-33 and its receptor does not prevent calcipotriol-induced atopic dermatitis-like inflammation in mice.
Volume: 10
Issue: 1
Pages: 6451
•
•
•
•
•
Publication
28194023 | J:311863
First Author: Tan Z
Year: 2018
Journal: Cell Mol Immunol
Title: Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
Volume: 15
Issue: 4
Pages: 388-398
•
•
•
•
•
Publication
23837438 | J:231563
First Author: Luzina IG
Year: 2013
Journal: Am J Respir Cell Mol Biol
Title: Interleukin-33 potentiates bleomycin-induced lung injury.
Volume: 49
Issue: 6
Pages: 999-1008
•
•
•
•
•
Publication
18523126 | J:139998
First Author: Yu XX
Year: 2008
Journal: Am J Physiol Endocrinol Metab
Title: Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
Volume: 295
Issue: 2
Pages: E436-45
•
•
•
•
•
Publication
30098206 | J:266863
First Author: Marques RE
Year: 2018
Journal: Immunology
Title: Interleukin-33 contributes to disease severity in Dengue virus infection in mice.
Volume: 155
Issue: 4
Pages: 477-490
•
•
•
•
•
Publication
32326950 | J:304200
First Author: Kasahara DI
Year: 2020
Journal: Respir Res
Title: IL-33, diet-induced obesity, and pulmonary responses to ozone.
Volume: 21
Issue: 1
Pages: 98
•
•
•
•
•
Publication
24985397 | J:310912
First Author: Li D
Year: 2014
Journal: J Allergy Clin Immunol
Title: IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.
Volume: 134
Issue: 6
Pages: 1422-1432.e11
•
•
•
•
•
Publication
29222107 | J:257763
First Author: Stier MT
Year: 2018
Journal: J Exp Med
Title: IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow.
Volume: 215
Issue: 1
Pages: 263-281
•
•
•
•
•
Publication
20689814 | J:163695
First Author: Hsu CL
Year: 2010
Journal: PLoS One
Title: IL-33 is produced by mast cells and regulates IgE-dependent inflammation.
Volume: 5
Issue: 8
Pages: e11944
•
•
•
•
•
Publication
31656879 | J:290546
 
First Author: Hussey GS
Year: 2019
Journal: J Immunol Regen Med
Title: Matrix bound nanovesicle-associated IL-33 activates a pro-remodeling macrophage phenotype via a non-canonical, ST2-independent pathway.
Volume: 3
Pages: 26-35
•
•
•
•
•
Publication
28448579 | J:246921
First Author: Reverchon F
Year: 2017
Journal: PLoS Pathog
Title: IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria.
Volume: 13
Issue: 4
Pages: e1006322
•
•
•
•
•
Publication
25692703 | J:259016
First Author: Endo Y
Year: 2015
Journal: Immunity
Title: The interleukin-33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway.
Volume: 42
Issue: 2
Pages: 294-308
•
•
•
•
•
Publication
30642984 | J:272891
First Author: O'Grady K
Year: 2019
Journal: J Immunol
Title: IL-33 Is a Negative Regulator of Vaccine-Induced Antigen-Specific Cellular Immunity.
Volume: 202
Issue: 4
Pages: 1145-1152
•
•
•
•
•
Publication
24045639 | J:327889
First Author: Rostan O
Year: 2013
Journal: mBio
Title: The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
Volume: 4
Issue: 5
Pages: e00383-13
•
•
•
•
•
Publication
17492053 | J:122103
First Author: Sanada S
Year: 2007
Journal: J Clin Invest
Title: IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
Volume: 117
Issue: 6
Pages: 1538-49
•
•
•
•
•
Publication
27701734 | J:241739
First Author: Theodoropoulou S
Year: 2017
Journal: J Pathol
Title: Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye.
Volume: 241
Issue: 1
Pages: 45-56
•
•
•
•
•
Publication
22585447 | J:187768
First Author: Jiang HR
Year: 2012
Journal: Eur J Immunol
Title: IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.
Volume: 42
Issue: 7
Pages: 1804-14
•
•
•
•
•
Publication
26310268 | J:230597
First Author: Zarpelon AC
Year: 2016
Journal: FASEB J
Title: Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain.
Volume: 30
Issue: 1
Pages: 54-65
•
•
•
•
•
Publication
23324173 | J:250052
First Author: Martin P
Year: 2013
Journal: Arthritis Res Ther
Title: Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency.
Volume: 15
Issue: 1
Pages: R13
•
•
•
•
•
Publication
30651000 | J:291394
First Author: Li J
Year: 2019
Journal: Arterioscler Thromb Vasc Biol
Title: IL (Interleukin)-33 Suppresses Abdominal Aortic Aneurysm by Enhancing Regulatory T-Cell Expansion and Activity.
Volume: 39
Issue: 3
Pages: 446-458
•
•
•
•
•
Publication
31221971 | J:278742
First Author: Frisbee AL
Year: 2019
Journal: Nat Commun
Title: IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection.
Volume: 10
Issue: 1
Pages: 2712
•
•
•
•
•
Publication
30856600 | J:290592
 
First Author: Luzina IG
Year: 2019
Journal: Cytokine
Title: Identification of the IL-33 protein segment that controls subcellular localization, extracellular secretion, and functional maturation.
Volume: 119
Pages: 1-6
•
•
•
•
•
Publication
28448566 | J:245944
First Author: Popovic B
Year: 2017
Journal: PLoS Pathog
Title: IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.
Volume: 13
Issue: 4
Pages: e1006345
•
•
•
•
•
Publication
27091974 | J:232212
First Author: Fu AK
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline.
Volume: 113
Issue: 19
Pages: E2705-13
•
•
•
•
•
Publication
25786179 | J:223817
First Author: Kearley J
Year: 2015
Journal: Immunity
Title: Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection.
Volume: 42
Issue: 3
Pages: 566-79
•
•
•
•
•
Publication
31053655 | J:290597
 
First Author: Mahlakõiv T
Year: 2019
Journal: Sci Immunol
Title: Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33.
Volume: 4
Issue: 35
•
•
•
•
•
Publication
30224451 | J:266672
First Author: Lopetuso LR
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair.
Volume: 115
Issue: 40
Pages: E9362-E9370
•
•
•
•
•
Publication
22542450 | J:184801
First Author: Ouziel R
Year: 2012
Journal: Am J Pathol
Title: The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice.
Volume: 180
Issue: 6
Pages: 2330-9
•
•
•
•
•
Publication
26322482 | J:233650
First Author: Guo L
Year: 2015
Journal: Nat Immunol
Title: Innate immunological function of TH2 cells in vivo.
Volume: 16
Issue: 10
Pages: 1051-9
•
•
•
•
•
Publication
26755704 | J:232649
First Author: Xi H
Year: 2016
Journal: J Exp Med
Title: IL-33 amplifies an innate immune response in the degenerating retina.
Volume: 213
Issue: 2
Pages: 189-207
•
•
•
•
•
Publication
27582256 | J:241900
 
First Author: Jackson-Jones LH
Year: 2016
Journal: Nat Commun
Title: Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation.
Volume: 7
Pages: 12651
•
•
•
•
•
Publication
26473724 | J:246763
First Author: Saravia J
Year: 2015
Journal: PLoS Pathog
Title: Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33.
Volume: 11
Issue: 10
Pages: e1005217
•
•
•
•
•
Publication
30763587 | J:271153
 
First Author: Garbern JC
Year: 2019
Journal: J Mol Cell Cardiol
Title: Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis.
Volume: 128
Pages: 179-186
•
•
•
•
•
Publication
21469105 | J:176634
First Author: Besnard AG
Year: 2011
Journal: Eur J Immunol
Title: IL-33-activated dendritic cells are critical for allergic airway inflammation.
Volume: 41
Issue: 6
Pages: 1675-86
•
•
•
•
•
Publication
35341735 | J:323883
     
First Author: Cheon SY
Year: 2022
Journal: J Invest Dermatol
Title: IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis.
•
•
•
•
•
Publication
30011081 | J:289613
First Author: Macari S
Year: 2018
Journal: J Cell Biochem
Title: ST2 regulates bone loss in a site-dependent and estrogen-dependent manner.
Volume: 119
Issue: 10
Pages: 8511-8521
•
•
•
•
•
Publication
23894196 | J:205821
First Author: Flaczyk A
Year: 2013
Journal: J Immunol
Title: IL-33 signaling regulates innate and adaptive immunity to Cryptococcus neoformans.
Volume: 191
Issue: 5
Pages: 2503-13
•
•
•
•
•
Publication
36603504 | J:332549
 
First Author: Luzina IG
Year: 2023
Journal: Cell Immunol
Title: Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashion.
Volume: 383
Pages: 104657
•
•
•
•
•
Publication
18667700 | J:139941
First Author: Xu D
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: IL-33 exacerbates antigen-induced arthritis by activating mast cells.
Volume: 105
Issue: 31
Pages: 10913-8
•
•
•
•
•
Publication
34354077 | J:314438
First Author: Ring SS
Year: 2021
Journal: Nat Commun
Title: Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment.
Volume: 12
Issue: 1
Pages: 4734
•
•
•
•
•
Publication
22634619 | J:188951
First Author: Luzina IG
Year: 2012
Journal: J Immunol
Title: Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion.
Volume: 189
Issue: 1
Pages: 403-10
•
•
•
•
•
Publication
34560104 | J:351163
First Author: Trier AM
Year: 2022
Journal: J Allergy Clin Immunol
Title: IL-33 signaling in sensory neurons promotes dry skin itch.
Volume: 149
Issue: 4
Pages: 1473-1480.e6
•
•
•
•
•
Publication
25814531 | J:222580
First Author: Reichenbach DK
Year: 2015
Journal: Blood
Title: The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.
Volume: 125
Issue: 20
Pages: 3183-92
•
•
•
•
•
Publication
31988179 | J:287491
First Author: Magat JM
Year: 2020
Journal: J Immunol
Title: Endogenous IL-33 and Its Autoamplification of IL-33/ST2 Pathway Play an Important Role in Asthma.
Volume: 204
Issue: 6
Pages: 1592-1597
•
•
•
•
•
Publication
36952346 | J:349834
First Author: Hou J
Year: 2023
Journal: Cell Rep
Title: Transcriptomic atlas and interaction networks of brain cells in mouse CNS demyelination and remyelination.
Volume: 42
Issue: 4
Pages: 112293
•
•
•
•
•
Publication
29887374 | J:265658
First Author: Li C
Year: 2018
Journal: Cell
Title: TCR Transgenic Mice Reveal Stepwise, Multi-site Acquisition of the Distinctive Fat-Treg Phenotype.
Volume: 174
Issue: 2
Pages: 285-299.e12
•
•
•
•
•
Publication
30696763 | J:271502
First Author: Ameri AH
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: IL-33/regulatory T cell axis triggers the development of a tumor-promoting immune environment in chronic inflammation.
Volume: 116
Issue: 7
Pages: 2646-2651
•
•
•
•
•
Publication
27340126 | J:239964
First Author: Noel G
Year: 2016
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Volume: 311
Issue: 2
Pages: G313-23
•
•
•
•
•
Publication
28450225 | J:252636
 
First Author: Veeraveedu PT
Year: 2017
Journal: Biochem Pharmacol
Title: Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress.
Volume: 138
Pages: 73-80
•
•
•
•
•
Publication
29674622 | J:274142
First Author: Chen WY
Year: 2018
Journal: Exp Mol Med
Title: IL-33/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury.
Volume: 50
Issue: 4
Pages: 36
•
•
•
•
•
Publication
27067050 | J:235184
First Author: Chen WY
Year: 2016
Journal: Biochem Biophys Res Commun
Title: Upregulation of Interleukin-33 in obstructive renal injury.
Volume: 473
Issue: 4
Pages: 1026-1032
•
•
•
•
•
Publication
26365875 | J:227003
 
First Author: Cohen ES
Year: 2015
Journal: Nat Commun
Title: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation.
Volume: 6
Pages: 8327
•
•
•
•
•
Publication
7499265 | J:29776
First Author: Kumar S
Year: 1995
Journal: J Biol Chem
Title: ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1.
Volume: 270
Issue: 46
Pages: 27905-13
•
•
•
•
•
Publication
27821781 | J:239108
First Author: Liu B
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy.
Volume: 113
Issue: 47
Pages: E7572-E7579
•
•
•
•
•
Publication
30001716 | J:289713
First Author: Babic ZM
Year: 2018
Journal: J Biomed Sci
Title: IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis.
Volume: 25
Issue: 1
Pages: 56
•
•
•
•
•
Publication
32102434 | J:298547
 
First Author: Chen WY
Year: 2020
Journal: Int J Mol Sci
Title: Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury.
Volume: 21
Issue: 4
•
•
•
•
•
Publication
32108542 | J:299814
First Author: Begum S
Year: 2020
Journal: J Histochem Cytochem
Title: Dynamic Expression of Interleukin-33 and ST2 in the Mouse Reproductive Tract Is Influenced by Superovulation.
Volume: 68
Issue: 4
Pages: 253-267
•
•
•
•
•
Publication
32571430 | J:302508
First Author: Lamberet A
Year: 2020
Journal: Parasit Vectors
Title: IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection.
Volume: 13
Issue: 1
Pages: 320
•
•
•
•
•
Publication
32582171 | J:305352
 
First Author: Boberg E
Year: 2020
Journal: Front Immunol
Title: Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Volume: 11
Pages: 1058
•
•
•
•
•
Publication
23347081 | J:318998
First Author: Zarpelon AC
Year: 2013
Journal: Br J Pharmacol
Title: IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.
Volume: 169
Issue: 1
Pages: 90-101
•
•
•
•
•
Publication
1833184 | J:1803
First Author: McMahan CJ
Year: 1991
Journal: EMBO J
Title: A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.
Volume: 10
Issue: 10
Pages: 2821-32
•
•
•
•
•
Publication
1832015 | J:11397
First Author: Tominaga S
Year: 1991
Journal: Biochim Biophys Acta
Title: Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping.
Volume: 1090
Issue: 1
Pages: 1-8
•
•
•
•
•
Publication
17675517 | J:151287
First Author: Chackerian AA
Year: 2007
Journal: J Immunol
Title: IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
Volume: 179
Issue: 4
Pages: 2551-5
•
•
•
•
•
Publication
18003919 | J:127627
First Author: Ali S
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.
Volume: 104
Issue: 47
Pages: 18660-5
•
•
•
•
•
Publication
29045903 | J:274274
First Author: Osbourn M
Year: 2017
Journal: Immunity
Title: HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33.
Volume: 47
Issue: 4
Pages: 739-751.e5
•
•
•
•
•
Publication
21239718 | J:169159
First Author: Komai-Koma M
Year: 2011
Journal: J Immunol
Title: IL-33 activates B1 cells and exacerbates contact sensitivity.
Volume: 186
Issue: 4
Pages: 2584-91
•
•
•
•
•
Publication
19506243 | J:150049
First Author: Pushparaj PN
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: The cytokine interleukin-33 mediates anaphylactic shock.
Volume: 106
Issue: 24
Pages: 9773-8
•
•
•
•
•
Publication
26872602 | J:233457
First Author: Aoki R
Year: 2016
Journal: J Invest Dermatol
Title: The Alarmin IL-33 Derived from HSV-2-Infected Keratinocytes Triggers Mast Cell-Mediated Antiviral Innate Immunity.
Volume: 136
Issue: 6
Pages: 1290-2
•
•
•
•
•
Publication
20634488 | J:175027
First Author: Miller AM
Year: 2010
Journal: Circ Res
Title: Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.
Volume: 107
Issue: 5
Pages: 650-8
•
•
•
•
•
Publication
36809763 | J:347462
First Author: Marx AF
Year: 2023
Journal: Immunity
Title: The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1(+) CD8(+) T cells in chronic viral infection.
Volume: 56
Issue: 4
Pages: 813-828.e10
•
•
•
•
•
Publication
26417439 | J:250083
First Author: Martin P
Year: 2015
Journal: Immun Inflamm Dis
Title: Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling.
Volume: 3
Issue: 3
Pages: 239-46
•
•
•
•
•
Publication
23071771 | J:192228
First Author: Kaieda S
Year: 2012
Journal: PLoS One
Title: Interleukin-33 primes mast cells for activation by IgG immune complexes.
Volume: 7
Issue: 10
Pages: e47252
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom